← Leaderboards
Chun Zhang Yang
Division Of Basic Sciences - Nci
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Division Of Basic Sciences - Nci
Same institution · by research overlap
Others in their field
Top investigators on “Glioma”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$158,144,386
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,436,447
- David Heimbrook · Leidos Biomedical Research, Inc.$56,561,099
- Gregory H Reaman · National Childhood Cancer Foundation$49,046,612
- Melissa L Bondy · Stanford University$36,047,564
- Brad H. Pollock · University Of Florida$28,646,726
Research focus
GliomaMutantMutateTumorPathway InteractionsCellsMetabolicMolecularMutationIsocitrate DehydrogenaseDisease OutcomeInterestTranscriptomicsMalignant NeoplasmsXenograft ProcedureAdoptedIn VivoKnock-DownGeneticBaseTumor ProgressionMouse ModelNovel TherapeuticsCell Line
Grant awards (26)
Investigating the metabolic vulnerability in glioma$395,001
ZIA · FY2025 · CA · contact PI
Chemo-sensitizing IDH1-mutated glioma by molecular targeting$395,001
ZIA · FY2025 · CA · contact PI
Establish Preclinical Model for Glioma Research$338,572
ZIA · FY2025 · CA · contact PI
Chemo-sensitizing IDH1-mutated glioma by molecular targeting$431,431
ZIA · FY2024 · CA · contact PI
Nrf2-goverened metabolic reprogram in IDH1-mutated glioma$431,431
ZIA · FY2024 · CA · contact PI
Establish Preclinical Model for IDH-mutated Glioma$369,798
ZIA · FY2024 · CA · contact PI
Nrf2-goverened metabolic reprogram in IDH1-mutated glioma$389,249
ZIA · FY2023 · CA · contact PI
Chemo-sensitizing IDH1-mutated glioma by molecular targeting$389,249
ZIA · FY2023 · CA · contact PI
Establish Preclinical Model for IDH-mutated Glioma$333,641
ZIA · FY2023 · CA · contact PI
Nrf2-goverened metabolic reprogram in IDH1-mutated glioma$405,414
ZIA · FY2022 · CA · contact PI
Chemo-sensitizing IDH1-mutated glioma by molecular targeting$405,414
ZIA · FY2022 · CA · contact PI
Establish Preclinical Model for IDH-mutated Glioma$347,497
ZIA · FY2022 · CA · contact PI
Chemo-sensitizing IDH1-mutated glioma by molecular targeting$351,882
ZIA · FY2021 · CA · contact PI
Nrf2-goverened metabolic reprogram in IDH1-mutated glioma$351,882
ZIA · FY2021 · CA · contact PI
Establish Preclinical Model for IDH-mutated Glioma$301,613
ZIA · FY2021 · CA · contact PI
Nrf2-goverened metabolic reprogram in IDH1-mutated glioma$412,574
ZIA · FY2020 · CA · contact PI
Chemo-sensitizing IDH1-mutated glioma by molecular targeting$412,574
ZIA · FY2020 · CA · contact PI
Establish Preclinical Model for IDH-mutated Glioma$353,634
ZIA · FY2020 · CA · contact PI
Chemo-sensitizing IDH1-mutated glioma by molecular targeting$259,414
ZIA · FY2019 · CA · contact PI
Nrf2-goverened metabolic reprogram in IDH1-mutated glioma$259,414
ZIA · FY2019 · CA · contact PI
Establish Preclinical Model for IDH-mutated Glioma$222,355
ZIA · FY2019 · CA · contact PI
Develop novel therapeutic strategy for brain tumor$482,273
ZIA · FY2018 · CA · contact PI
Investigation on the biology of IDH mutant glioma$206,689
ZIA · FY2018 · CA · contact PI
Understand glioma biology$403,189
ZIA · FY2017 · CA · contact PI
Develop novel therapeutic strategy for brain tumor$302,392
ZIA · FY2017 · CA · contact PI
Investigation on the biology of IDH mutant glioma$302,392
ZIA · FY2017 · CA · contact PI